<p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）在周日发布的研究报告中被华尔街 Zen 从 “持有” 评级上调至 “买入” 评级。</p>
<p>其他研究分析师最近也发布了关于该股票的研究报告。Weiss Ratings 在 12 月 29 日的报告中重申了对 Maximus 股票的 “买入（B-）” 评级。Zacks Research 在 12 月 30 日的研究报告中将 Maximus 的评级从 “持有” 上调至 “强力买入”。一位研究分析师给予该股票 “强力买入” 评级，另一位则给予 “买入” 评级。根据 MarketBeat.com 的数据，该股票的共识评级为 “强力买入”。</p>
<p><strong>查看我们对 MMS 的最新分析</strong></p>
<h2>Maximus 股价上涨 1.4%</h2>
<p>MMS 股票在周五开盘价为 74.75 美元。该公司的速动比率为 2.34，流动比率为 2.34，债务与股本比率为 0.88。该股票的 50 日简单移动平均为 89.09 美元，200 日简单移动平均为 86.58 美元。Maximus 的 52 周低点为 63.77 美元，52 周高点为 100.00 美元。该股票的市值为 40.8 亿美元，市盈率为 11.38，贝塔值为 0.57。</p>
<p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）最后一次发布财报是在 2 月 5 日，健康服务提供商报告该季度每股收益为 1.85 美元，超出共识预期的 1.84 美元 0.01 美元。该季度的营业收入为 13.5 亿美元，而共识预期为 13.7 亿美元。Maximus 的净利润率为 6.92%，股本回报率为 25.30%。该公司的季度收入较去年同期下降了 4.1%。去年同期，该公司每股收益为 1.61 美元。Maximus 已将其 2026 财年的指导目标设定为每股收益 8.050-8.350 美元。平均而言，卖方分析师预计 Maximus 在当前财年将发布每股收益 6.15 美元。</p>
<h2>Maximus 内部活动</h2>
<p>在其他 Maximus 的新闻中，内部人士 Michelle F. Link 在 12 月 3 日的交易中出售了 4,039 股该股票。股份以平均价格 86.84 美元出售，总交易额为 350,746.76 美元。交易后，内部人士在公司中持有 19,542 股，价值 1,697,027.28 美元。这代表其持股比例下降了 17.13%。该出售在向 SEC 提交的文件中披露，文件可通过此链接获取。此外，首席执行官 Bruce Caswell 在 2 月 10 日的交易中购买了 3,175 股公司的股票。该股票以每股 78.45 美元的平均成本购买，总价值为 249,078.75 美元。购买后，首席执行官持有 328,013 股公司的股票，价值 25,732,619.85 美元。这代表其持股比例增加了 0.98%。该购买的披露信息可在 SEC 文件中找到。在过去的九十天里，内部人士购买了价值 329,521 美元的 4,231 股公司股票。内部人士持有公司股票的比例为 1.80%。</p>
<h2>对 Maximus 的对冲基金看法</h2>
<p>机构投资者最近增加或减少了对该股票的持股。加拿大皇家银行在第一季度将其在 Maximus 的持股比例提高了 146.2%。加拿大皇家银行现在拥有 19,732 股健康服务提供商的股票，价值 1,345,000 美元，此前在上个季度增持了 11,716 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Maximus 的持股比例提高了 0.6%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 34,476 股健康服务提供商的股票，价值 2,351,000 美元，此前在上个季度增持了 221 股。瑞银资产管理美国有限公司的一个独立业务部门在第一季度将其在 Maximus 的持股比例提高了 7.0%。瑞银资产管理美国有限公司的一个独立业务部门现在拥有 180,690 股健康服务提供商的股票，价值 12,321,000 美元，此前在上个季度增持了 11,754 股。Jane Street Group LLC 在第一季度将其在 Maximus 的持股比例提高了 941.2%。Jane Street Group LLC 现在拥有 98,273 股健康服务提供商的股票，价值 6,701,000 美元，此前在上个季度增持了 88,835 股。最后，Sivia Capital Partners LLC 在第二季度购买了 Maximus 的新股份，价值约 204,000 美元。目前 97.21% 的股票由机构投资者和对冲基金持有。</p>
<h2>Maximus 公司简介</h2>
<p>（获取免费报告）</p>
<p>Maximus, Inc.（纽约证券交易所代码：MMS）是一家全球政府服务提供商，专注于提供健康和人类服务项目。该公司与联邦、州和地方机构合作，管理和实施支持个人和家庭在不同生活阶段的项目。主要服务领域包括医疗补助、医疗保险、儿童健康保险计划（CHIP）及其他公共援助项目的资格认定和入学服务，以及呼叫中心运营、案件管理和项目完整性解决方案。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票比 Maximus 更好</li>
<li>你的银行账户不再安全</li>
<li>Nvidia 首席执行官发布大胆的特斯拉预测</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>黄金市场崩溃的那一天</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Maximus 吗？</h2>
<p>在你考虑 Maximus 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Maximus 并不在名单上。</p>
<p>虽然 Maximus 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>华尔街禅将 Maximus（纽约证券交易所代码：MMS）的评级从 “持有” 上调至 “买入”。其他分析师，包括 Weiss Ratings 和 Zacks Research，也发布了积极的评级。Maximus 的股票开盘价为 74.75 美元，市值为 40.8 亿美元，市盈率为 11.38。公司报告的每股收益为 1.85 美元，略高于预期，但收入同比下降了 4.1%。内部交易包括 Michelle F. Link 的出售和首席执行官 Bruce Caswell 的购买。机构投资者持有 97.21% 的股份，显示出强烈的机构兴趣</p>

<p>Maximus (NYSE:MMS - Get Free Report) was upgraded by Wall Street Zen from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report issued on Sunday.</p>
<div class="lb-trans"><p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）在周日发布的研究报告中被华尔街 Zen 从 “持有” 评级上调至 “买入” 评级。</p>
</div><p>Other research analysts also recently issued research reports about the stock. Weiss Ratings reiterated a &#34;buy (b-)&#34; rating on shares of Maximus in a report on Monday, December 29th. Zacks Research upgraded Maximus from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of &#34;Strong Buy&#34;.</p>
<div class="lb-trans"><p>其他研究分析师最近也发布了关于该股票的研究报告。Weiss Ratings 在 12 月 29 日的报告中重申了对 Maximus 股票的 “买入（B-）” 评级。Zacks Research 在 12 月 30 日的研究报告中将 Maximus 的评级从 “持有” 上调至 “强力买入”。一位研究分析师给予该股票 “强力买入” 评级，另一位则给予 “买入” 评级。根据 MarketBeat.com 的数据，该股票的共识评级为 “强力买入”。</p>
</div><p><strong>View Our Latest Analysis on MMS</strong></p>
<div class="lb-trans"><p><strong>查看我们对 MMS 的最新分析</strong></p>
</div><h2>Maximus Trading Up 1.4%</h2>
<div class="lb-trans"><h2>Maximus 股价上涨 1.4%</h2>
</div><p>Shares of MMS stock opened at $74.75 on Friday. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. The stock has a 50-day simple moving average of $89.09 and a 200 day simple moving average of $86.58. Maximus has a fifty-two week low of $63.77 and a fifty-two week high of $100.00. The stock has a market capitalization of $4.08 billion, a P/E ratio of 11.38 and a beta of 0.57.</p>
<div class="lb-trans"><p>MMS 股票在周五开盘价为 74.75 美元。该公司的速动比率为 2.34，流动比率为 2.34，债务与股本比率为 0.88。该股票的 50 日简单移动平均为 89.09 美元，200 日简单移动平均为 86.58 美元。Maximus 的 52 周低点为 63.77 美元，52 周高点为 100.00 美元。该股票的市值为 40.8 亿美元，市盈率为 11.38，贝塔值为 0.57。</p>
</div><p>Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.01. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period last year, the firm posted $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, sell-side analysts expect that Maximus will post 6.15 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）最后一次发布财报是在 2 月 5 日，健康服务提供商报告该季度每股收益为 1.85 美元，超出共识预期的 1.84 美元 0.01 美元。该季度的营业收入为 13.5 亿美元，而共识预期为 13.7 亿美元。Maximus 的净利润率为 6.92%，股本回报率为 25.30%。该公司的季度收入较去年同期下降了 4.1%。去年同期，该公司每股收益为 1.61 美元。Maximus 已将其 2026 财年的指导目标设定为每股收益 8.050-8.350 美元。平均而言，卖方分析师预计 Maximus 在当前财年将发布每股收益 6.15 美元。</p>
</div><h2>Insider Activity at Maximus</h2>
<div class="lb-trans"><h2>Maximus 内部活动</h2>
</div><p>In other Maximus news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the transaction, the insider owned 19,542 shares in the company, valued at $1,697,027.28. This represents a 17.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bruce Caswell purchased 3,175 shares of the company's stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average cost of $78.45 per share, with a total value of $249,078.75. Following the purchase, the chief executive officer owned 328,013 shares of the company's stock, valued at $25,732,619.85. This represents a 0.98% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders bought 4,231 shares of company stock worth $329,521. Insiders own 1.80% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Maximus 的新闻中，内部人士 Michelle F. Link 在 12 月 3 日的交易中出售了 4,039 股该股票。股份以平均价格 86.84 美元出售，总交易额为 350,746.76 美元。交易后，内部人士在公司中持有 19,542 股，价值 1,697,027.28 美元。这代表其持股比例下降了 17.13%。该出售在向 SEC 提交的文件中披露，文件可通过此链接获取。此外，首席执行官 Bruce Caswell 在 2 月 10 日的交易中购买了 3,175 股公司的股票。该股票以每股 78.45 美元的平均成本购买，总价值为 249,078.75 美元。购买后，首席执行官持有 328,013 股公司的股票，价值 25,732,619.85 美元。这代表其持股比例增加了 0.98%。该购买的披露信息可在 SEC 文件中找到。在过去的九十天里，内部人士购买了价值 329,521 美元的 4,231 股公司股票。内部人士持有公司股票的比例为 1.80%。</p>
</div><h2>Hedge Funds Weigh In On Maximus</h2>
<div class="lb-trans"><h2>对 Maximus 的对冲基金看法</h2>
</div><p>Institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada raised its position in shares of Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider's stock worth $1,345,000 after acquiring an additional 11,716 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after acquiring an additional 221 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Maximus by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider's stock valued at $12,321,000 after buying an additional 11,754 shares during the last quarter. Jane Street Group LLC boosted its holdings in Maximus by 941.2% during the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider's stock worth $6,701,000 after acquiring an additional 88,835 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in Maximus in the 2nd quarter worth about $204,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>机构投资者最近增加或减少了对该股票的持股。加拿大皇家银行在第一季度将其在 Maximus 的持股比例提高了 146.2%。加拿大皇家银行现在拥有 19,732 股健康服务提供商的股票，价值 1,345,000 美元，此前在上个季度增持了 11,716 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Maximus 的持股比例提高了 0.6%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 34,476 股健康服务提供商的股票，价值 2,351,000 美元，此前在上个季度增持了 221 股。瑞银资产管理美国有限公司的一个独立业务部门在第一季度将其在 Maximus 的持股比例提高了 7.0%。瑞银资产管理美国有限公司的一个独立业务部门现在拥有 180,690 股健康服务提供商的股票，价值 12,321,000 美元，此前在上个季度增持了 11,754 股。Jane Street Group LLC 在第一季度将其在 Maximus 的持股比例提高了 941.2%。Jane Street Group LLC 现在拥有 98,273 股健康服务提供商的股票，价值 6,701,000 美元，此前在上个季度增持了 88,835 股。最后，Sivia Capital Partners LLC 在第二季度购买了 Maximus 的新股份，价值约 204,000 美元。目前 97.21% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Maximus Company Profile</h2>
<div class="lb-trans"><h2>Maximus 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.</p>
<div class="lb-trans"><p>Maximus, Inc.（纽约证券交易所代码：MMS）是一家全球政府服务提供商，专注于提供健康和人类服务项目。该公司与联邦、州和地方机构合作，管理和实施支持个人和家庭在不同生活阶段的项目。主要服务领域包括医疗补助、医疗保险、儿童健康保险计划（CHIP）及其他公共援助项目的资格认定和入学服务，以及呼叫中心运营、案件管理和项目完整性解决方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Maximus</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Nvidia CEO Issues Bold Tesla Call</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>The day the gold market broke</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Maximus 更好</li>
<li>你的银行账户不再安全</li>
<li>Nvidia 首席执行官发布大胆的特斯拉预测</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>黄金市场崩溃的那一天</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Maximus Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Maximus 吗？</h2>
</div><p>Before you consider Maximus, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Maximus 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Maximus 并不在名单上。</p>
</div><p>While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Maximus 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Maximus（纽约证券交易所代码：MMS）被华尔街禅提升至买入评级